Jan 23, 2026 12:56PM
Nov 10, 2025 10:01AM
Oct 1, 2025 01:20PM
Jul 20, 2025 08:00PM
Jan 27, 2025 07:50AM
Jan 24, 2025 07:33AM
Jan 13, 2025 12:50PM RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA
Jan 12, 2025 05:01PM
Dec 19, 2024 01:40PM
Dec 19, 2024 06:00AM
Dec 19, 2024 06:00AM
Nov 13, 2024 04:08PM
Nov 5, 2024 01:11PM
Nov 4, 2024 04:01PM Vertex Reports Third Quarter 2024 Financial Results
Oct 21, 2024 06:05AM
Oct 18, 2024 08:00AM
Oct 18, 2024 08:00AM
Sep 26, 2024 07:08AM
Sep 26, 2024 07:07AM
Aug 5, 2024 07:46AM
Aug 2, 2024 07:45AM Vertex (VRTX) PT Raised to $535 at Piper Sandler
Aug 1, 2024 04:01PM
Jul 30, 2024 01:10PM
Jul 30, 2024 01:10PM
Jul 2, 2024 08:33AM
Jul 2, 2024 08:33AM
Jan 16, 2024 02:24PM
Jan 16, 2024 02:24PM Vertex Announces US FDA Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Transfusion-Dependent Beta Thalassemia
Jan 8, 2024 05:26AM
Jan 7, 2024 03:00PM
Dec 12, 2023 03:21AM
Dec 11, 2023 07:30PM
Dec 8, 2023 12:55PM
Dec 8, 2023 12:52PM
Nov 16, 2023 04:53AM Vertex Pharma (VRTX) and CRISPR Therapeutics (CRSP) Announce Authorization of the CASGEVY in the UK
Nov 16, 2023 01:45AM
Nov 6, 2023 04:01PM
Aug 1, 2023 04:01PM
Jun 9, 2023 05:35AM
Jun 9, 2023 05:29AM
Jun 9, 2023 03:01AM
Jun 8, 2023 07:23PM FDA Accepts Biologics License Applications for exagamglogene autotemcel (exa-cel) for Severe Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
May 1, 2023 04:01PM
Feb 7, 2023 04:01PM
Aug 4, 2022 04:01PM
Feb 1, 2021 04:01PM
Jan 26, 2021 08:31AM
Jan 26, 2021 08:30AM
Sep 1, 2020 09:03AM Vertex Pharma (VRTX) Announces FDA Accepts its sNDA for TRIKAFTA, SYMDEKO and KALYDECO for Additional CFTR Mutations
Sep 1, 2020 09:00AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All